Discover how relative value funds use strategies like pairs trading to exploit mispricings, aiming to exceed benchmarks. Learn with examples and analysis on active fund management.

Artificial intelligence spikes and sell-offs, market-rattling tariffs from the world's largest economy, mysterious quant ...

Hedge funds have profited handsomely from fee income over the past 50 years or so, but they are now having to adopt new models more closely aligned with performance as pressure from institutional ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Our mainFT colleagues Harriet Agnew and Ortenca Aliaj have written a great piece on the recent dominance of the ...

MicroStrategy Inc. (NASDAQ:MSTR) is attracting hedge fund interest through its convertible notes offerings, as co-founder Michael Saylor continues his aggressive Bitcoin (CRYPTO: BTC) purchase ...

The global hedge fund industry has surged past the $5 trillion asset mark, a milestone reflecting not only strong performance but also an evolution in how hedge funds position themselves in investment ...

Hedge funds can make returns of 30% and more a year but Wall Street says only the rich can invest. In this video, I’ll explain hedge fund investing and how hedge funds work. I’ll show you examples of ...

The first half of 2025 has proven disappointing for hedge funds, largely due to the uncertainty surrounding US policymaking. However, there are good reasons to believe that the outlook should improve ...

Simply sign up to the US companies myFT Digest -- delivered directly to your inbox. Hedge fund crowding has been pretty extreme over the past year, but many big players are now paring back their ...

Justin Zhen, cofounder of web-scraping data vendor Thinknum, said his company and four others have maintained an informal blacklist for two years.

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Bradley Saacks Every time Bradley publishes a story, you’ll get an alert straight to your inbox ...

Ever since an HIV/Aids patient advocacy group began raising questions last week about why Turing Pharmaceuticals jacked up the price for a medication from $13.50 per pill to $750 overnight, anger ...